Metraipolis › archive › dc_91c071fe62ba

Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer — Europe PMC PMID:42279425

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279425
DOI
10.3390/cancers18111843
License (as archived)
solo-consultazione
Archived
2026-10-31T19:50:47.356Z
SHA-256 of the archived text
dcb845b9f4f87f594c3479c2d649fe3ff05c47b2c2a2e363283d393df335f98a
Stable URL of this page
https://metraipolis.com/documento/dc_91c071fe62ba

How to cite

Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer — Europe PMC PMID:42279425 — Europe PMC (en), https://europepmc.org/article/MED/42279425 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_91c071fe62ba (Metraipolis archive dc_91c071fe62ba, sha256 dcb845b9f4f87f594c3479c2d649fe3ff05c47b2c2a2e363283d393df335f98a)
BibTeX
@misc{dc91c071fe62ba,
  title = {Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer — Europe PMC PMID:42279425},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279425},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_91c071fe62ba; sha256 dcb845b9f4f87f594c3479c2d649fe3ff05c47b2c2a2e363283d393df335f98a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279425. Agents can read the archived copy with the MCP tool read_document.